Literature DB >> 21939922

Fulminant ulcerative colitis despite maximal immunosuppression following liver transplantation: a case report and literature review.

Antony Pan1, Martin Schlup, Ralf Lubcke, Michael Schultz.   

Abstract

Inflammatory Bowel Disease (IBD) is thought to be the result of an overly aggressive immune response to ubiquitous antigens. Immuno -modulation and -suppression is therefore currently the treatment of choice. It was long anticipated that the course of pre-existing IBD should improve after orthotopic liver transplantation (OLT) due to increased immunosuppression. We report the case of a patient who developed acute fulminant colitis despite triple immunosuppression and mesalazine and review the relevant literature.
Copyright © 2011 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21939922     DOI： 10.1016/j.crohns.2011.04.011

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN： 1873-9946            Impact factor:   9.071


  3 in total

1.  A Review of Inflammatory Bowel Disease in the Setting of Liver Transplantation.

Authors:  Veena Nannegari; Saenz Roque; David T Rubin; Rodrigo Quera
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-10

Review 2.  Management of ulcerative colitis pre- and post-liver transplant for primary sclerosing cholangitis: two case reports and review of literature.

Authors:  Kiranpreet Khosa; Kofi Clarke
Journal:  Int J Colorectal Dis       Date:  2014-07-04       Impact factor: 2.571

3.  The effect of liver transplantation for primary sclerosing cholangitis on disease activity in patients with inflammatory bowel disease.

Authors:  Mahmoud Mosli; Kristopher Croome; Karim Qumosani; Bandar Al-Judaibi; Melanie Beaton; Paul Marotta; Natasha Chandok
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.